Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
A Klein, I Becker, K Minden, I Foeldvari, JP Haas & G Horneff. (2019) Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry. Scandinavian Journal of Rheumatology 48:2, pages 95-104.
Read now
Read now
Gerd Horneff. (2015) Safety of biologic therapies for the treatment of juvenile idiopathic arthritis. Expert Opinion on Drug Safety 14:7, pages 1111-1126.
Read now
Read now
Gerd Horneff. (2013) Update on biologicals for treatment of juvenile idiopathic arthritis. Expert Opinion on Biological Therapy 13:3, pages 361-376.
Read now
Read now
Articles from other publishers (22)
Jae Hyun JUNG, Hongdeok SEOK, Cho Hee BANG, Cholhee KIM, Gwan Gyo SONG & Sung Jae CHOI. (2022) Association between interleukin-1, interleukin-6, and tumor necrosis factor-alpha polymorphisms and juvenile idiopathic arthritis: a meta-analysis. Minerva Pediatrics 74:2.
Crossref
Crossref
Gerd Horneff. (2021) Biosimilars in der Kinderrheumatologie. Kinder- und Jugendmedizin 21:05, pages 339-348.
Crossref
Crossref
Deniz Aygun, Sezgin Sahin, Amra Adrovic, Kenan Barut, Haluk Cokugras, Yıldız Camcıoglu & Ozgur Kasapcopur. (2018) The frequency of infections in patients with juvenile idiopathic arthritis on biologic agents: 1-year prospective study. Clinical Rheumatology 38:4, pages 1025-1030.
Crossref
Crossref
Marisa Christin Beck, Anne-Marie Glimm, Sarah Ohrndorf, Kirsten Minden, Ralf Trauzeddel, Stephanie Gabriele Werner, Gerd Horneff, Marina Backhaus, Gerd Rüdiger Burmester, Tilmann Kallinich, Hermann Girschick & Jens Klotsche. (2017) Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography. Arthritis Research & Therapy 19:1.
Crossref
Crossref
Jenny Schlichtiger, Johannes-Peter Haas, Swaantje Barth, Betty Bisdorff, Lisa Hager, Hartmut Michels, Boris Hügle & Katja Radon. (2017) Education and employment in patients with juvenile idiopathic arthritis – a standardized comparison to the German general population. Pediatric Rheumatology 15:1.
Crossref
Crossref
Juan Zhou, Yuan Ding, Yu Zhang, Ye Feng, Xuemei Tang & Xiaodong Zhao. (2017) CD3 + CD56 + natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroup. Clinical Immunology 176, pages 1-11.
Crossref
Crossref
Sujata Sawhney, Abhay Shivpuri & Amita Aggarwal. 2017. Pediatric Rheumatology. Pediatric Rheumatology
247
261
.
Gerd Horneff, Ariane Klein, Jens Klotsche, Kirsten Minden, Hans-Iko Huppertz, Frank Weller-Heinemann, Jasmin Kuemmerle-Deschner, Johannes-Peter Haas & Anton Hospach. (2016) Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Swaantje Barth, Jenny Schlichtiger, Betty Bisdorff, Boris Hügle, Hartmut Michels, Katja Radon & Johannes-Peter Haas. (2016) Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case–control study. Pediatric Rheumatology 14:1.
Crossref
Crossref
Gerd Horneff. (2015) Biologic-Associated Infections in Pediatric Rheumatology. Current Rheumatology Reports 17:11.
Crossref
Crossref
H.-I. Huppertz, G. Horneff & F. Zepp. 2015. Pädiatrie. Pädiatrie
1
25
.
Heinrike Schmeling, Kirsten Minden, Ivan Foeldvari, Gerd Ganser, Tony Hospach & Gerd Horneff. (2014) Efficacy and Safety of Adalimumab as the First and Second Biologic Agent in Juvenile Idiopathic Arthritis: The German Biologics JIA Registry. Arthritis & Rheumatology 66:9, pages 2580-2589.
Crossref
Crossref
Gerd Horneff & Ingrid Becker. (2014) Definition of improvement in juvenile idiopathic arthritis using the Juvenile Arthritis Disease Activity Score. Rheumatology 53:7, pages 1229-1234.
Crossref
Crossref
Hans-Iko Huppertz, Gerd Horneff & Fred Zepp. 2014. Pädiatrie. Pädiatrie
750
764
.
Juan Zhou, Xuemei Tang, Yuan Ding, Yunfei An & Xiaodong Zhao. (2013) Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis. Pediatric Allergy and Immunology 24:7, pages 691-696.
Crossref
Crossref
Ariane Klein & Gerd Horneff. (2013) Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis. Clinical Investigation 3:5, pages 493-504.
Crossref
Crossref
Sujata Sawhney. (2012) Juvenile idiopathic arthritis: Classification, clinical features, and management. Indian Journal of Rheumatology 7:1, pages 11-21.
Crossref
Crossref
R. Gurion, T. J. A. Lehman & L. N. Moorthy. (2012) Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment. International Journal of Inflammation 2012, pages 1-16.
Crossref
Crossref
G. Horneff, I. Foeldvari, K. Minden, D. Moebius & T. Hospach. (2010) Report on malignancies in the German juvenile idiopathic arthritis registry. Rheumatology 50:1, pages 230-236.
Crossref
Crossref
V. Papsdorf & G. Horneff. (2010) Complete control of disease activity and remission induced by treatment with etanercept in juvenile idiopathic arthritis. Rheumatology 50:1, pages 214-221.
Crossref
Crossref
G. Horneff. (2010) Malignome und Tumor-Nekrose-Faktor-Inhibitoren bei der juvenilen idiopathischen ArthritisMalignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis. Zeitschrift für Rheumatologie 69:6, pages 516-526.
Crossref
Crossref
Susan Shenoi & Carol A. Wallace. (2010) Remission in Juvenile Idiopathic Arthritis: Current Facts. Current Rheumatology Reports 12:2, pages 80-86.
Crossref
Crossref